Maralixibat
CAS 716313-53-0Small Molecule
Overview
Maralixibat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL363392).
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Maralixibat expires 5 Oct 2043 and exclusivity 24 Jul 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-4-ol
- Canonical SMILES
- CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC
- InChIKey
- STPKWKPURVSAJF-LJEWAXOPSA-N
Verified Supplier Partner
Do you supply Maralixibat? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.